Technology transfer from the science of medicine to the real world: The potential role played by artificial adaptive systems

Substance Use and Misuse

Volumn 42, Issue 2-3, 2007, Pages 267-304

  Grossi, Enzo ^a  

^a Bracco SpA   (Italy)

Author keywords

Artificial adaptive systems (AAS); Artificial neural networks (ANNs); Effectiveness; Efficiency; Evidence based medicine (EBM); Evolutionary algorithms (EA); Mapping; Medical errors; Non linearity; Randomised clinical trial (RCT); Statistical innumeracy

Indexed keywords

ALGORITHM; ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL NEURAL NETWORK; ATROPHIC GASTRITIS; COMPUTER AIDED DESIGN; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DATA BASE; DECISION MAKING; DIAGNOSTIC ERROR; DISCRIMINANT ANALYSIS; DYSPEPSIA; ECHOGRAPHY; ELECTROENCEPHALOGRAM; EPILEPSY; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HEALTH CARE PERSONNEL; HOSPITAL INFORMATION SYSTEM; HUMAN; IRRITABLE COLON; LAPAROSCOPY; MAMMOGRAPHY; MEDICAL ERROR; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICINE; PATIENT CARE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STATISTICS; SYMPTOMATOLOGY; TECHNOLOGY; UTERINE CERVIX CARCINOMA;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; BIOMEDICAL RESEARCH; DECISION MAKING, COMPUTER-ASSISTED; DIFFUSION OF INNOVATION; EVIDENCE-BASED MEDICINE; FUZZY LOGIC; HUMANISM; HUMANS; MEDICAL ERRORS; NONLINEAR DYNAMICS; PHILOSOPHY, MEDICAL; RANDOMIZED CONTROLLED TRIALS; TECHNOLOGY TRANSFER; TECHNOLOGY, MEDICAL;

EID: 34250173865     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080601142006     Document Type: Article

References (54)

1. Ahmad, K. (2002). Lectures on fuzzy logic and fuzzy systems. https://www.cs.tcd.ie/Khurshid.Ahmad/Fuzzy%20Logic%20Fuzzy%20control%20Systems Outline.pdf
2. Andriulli, A., Grossi, E., Buscema, M., Festa, V., Intraligi, N. M., Dominici, P., et al. (2003). Contribution of artificial neural networks to the classification and treatment of patients with uninvestigated dyspepsia. Digestive and Liver Disease 35:222-231.
3. Bates, D. W., Cohen, M., Leape, L. L., Overhage, M., Shabot, M., Sheridan, T. (2001). Reducing the frequency of errors in medicine using information technology. Journal of the American Medical Informatics Association 8:299-308.
4. Blacker, C. V. R., Mortimore, L. (1996). Randomized controlled trials and naturalistic data: Time for a change? Human Psychopharmacology 11:353-363.
5. Bland, J. M., Kerry, S. M. (1997). Trials randomized in clusters. British Medical Journal 315:600.
6. Block, G. (1996). Are clinical trials really the answer? American Journal of Clinical Nutrition 62:1517-1520.
7. Brent, C. Retrieved from http://www.himss.org/content/files/proceedings/ 2002
8. Buscema, M. (2002). A brief overview and introduction to artificial neural networks. Substance Use & Misuse 37(8-10):1093-1148.
9. Buscema, M. (2004). Genetic doping algorithm (GenD): Theory and applications. Expert Systems 21(2):63-80.
10. Charlton, B. G. (1996). The scope and nature of epidemiology. Journal of Clinical Epidemiology 49:623-626.
11. Charlton, B. G. (2001). Commentary: Fundamental deficiencies in themegatrial methodology. Current Controlled Trials in Cardiovascular Medicine 2:2-7.
12. Chassin, M. (1998). Is health care ready for six sigma quality? Milbank Quarterly 76(4):1-14.
13. Chassin, M. R., Galvin, R. W., the National Roundtable on Health Care Quality. (1998). The urgent need to improve health care quality. Journal of the American Medical Association 280(11):1000-1005.
14. de Carvalho, M. (2002). Medical errors in hospitalized patients. Journal of Pediatrics 78(4):261-268.
15. Feinstein, A. R. (1994). Art, science, and the doctor-patient relationship. Annals of the New York Academy of Sciences 729:19-21.
16. Flum, D. R., Morris, A., Koepsell, T., Patchen Dellinger, E. (2001). Has misdiagnosis of appendicitis decreased over time? A population-based analysis. Journal of the American Medical Association 286:1748-1753.
17. Gigerenzer, G., Edwards, A. (2003). Simple tools for understanding risks: From innumeracy to insight. British Medical Journal 327:741-744.
18. Glouberman, S., Zimmerman, B. (2002). Complicated and complex systems: What would successful reform of Medicare look like? [Discussion paper no. 8]. Commission on the Future of Health in Canada. York University.
19. Goldberger, A. L. (1996). Nonlinear dynamics for clinicians: Chaos theory, fractals, and complexity at the bedside. Lancet 347:1312-1314.
20. Gollub, J. P., Cross, M. C. (2000). Nonlinear dynamics: Chaos in space and time. Nature 404:710-711.
21. Goodwin, J. (1997). Chaos and the limits of modern medicine. Journal of the American Medical Association 278:1399-1400.
22. Hlatky, M. A., Cotugno, H. E., Mark, D. B., O'Connor, C., Califf, R. M., Pryor, D. B. (1988). Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. American Journal of Cardiology 61(8):515-518.
23. Horvitz, R. I., Singer, B. H., Makuch, R. W., Viscoli, C. M. (1996). Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information-needs of clinical inquiry and drug regulation. Journal of Clinical Epidemiology 49:395-400.
24. Horwitz, R. I., Viscoli, C. M., Clemens, J. D., Sadock, R. T. (1990). Developing improved observational methods for evaluating therapeutic effectiveness. American Journal of Medicine 89(5):630-638.
25. Ioannidis, J. P. (2004). Materializing research promises: Opportunities, priorities and conflicts in translational medicine. Journal of Translational Medicine 2(1):5.
26. Joffe, M. M., Rosenbaum, P. R. (1999). Invited commentary: Propensity scores. American Journal of Epidemiology 150(4):327-333.
27. Kahneman, D., Slovic, P., Tverskey, A. (1982). Judgment under uncertainty: Heuristics and biases. Cambridge University Press, Cambridge.
28. Kaplan, D., Glass, L. (1995). Understanding nonlinear dynamics. New York: Springer-Verlag.
29. Kattan, M. (2002). Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic," Journal of Clinical Oncology 20:885-887.
30. Kroll, M. H. (1999). Biological variation of glucose and insulin includes a deterministic chaotic component. Biosystems 50:189-201.
31. Leape (1999). To err is human. Building a safer health system. Washington, DC: National Academy Press.
32. Lisboa, P. J. G. (2002). A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Networks 15(1):11-39.
33. Longstreth, G. F. (1997). Irritable bowel syndrome. Diagnosis in the managed care era. Digestive Diseases and Sciences 42(6):1105-1111.
34. Marshall, G., Blacklock, J. W. S., Cameron, C., Capon, N. B., Cruikckheank, R., Gdaddum, J. H., Heaf, F. R. G., Bradford Hill, A., Houghton, L. E., Hoyle, J. Clifford, Raistrick, H., Scadding J. G., Tytler, W. H., Wilson, G. S., Hart, P. D'Arcy et al. (1948 Oct 30) Streptomycin treatment of pulmonary tuberculosis. British Medical Journal iii(4582):769-782.
35. Mayer, P. L., Awad, I. A., Todor, R., Harbaugh, K., Varnavas, G., Lansen, T. A., et al. (1996). Misdiagnosis of symptomatic cerebral aneurysm: Prevalence and correlation with outcome at four institutions. Stroke 27:1558-1563.
36. Mecocci, P., Grossi, E., Buscema, M., Intraligi, M., Savare, R., Rinaldi, P., et al. (2002). Use of artificial networks in clinical trials: A pilot study to predict responsiveness to Donepezil in Alzheimer's disease. Journal of the American Geriatrics Society 50(11):1857-1860.
37. Miller, G. A. (1956). The magical number seven, plus or minus two: Some limits on our capacity for processing information. The Psychological Review 63:81-97.
38. Moses, L. E. (1995). Measuring effects without randomized trials? Options, problems, challenges. Medical Care 33(Suppl. 4):AS8-AS14.
39. Muir-Gray, J. A. (1999). National electronic Library for Health (NeLH) Information in practice. British Medical Journal 319:1476.
40. Naguib, R. (2002, February 6). When conclusions are hypotheses: Artificial intelligence and cancer research (Lecture). Leicester: De Montfort University.
41. Nowack, W. J. (1997). Epilepsy: A costly misdiagnosis. Clinical Electroencephalography 28(4):225-228.
42. Peto, R., Collins, R., Gray, R. (1993). Large-scale randomized evidence: Large, simple trials and overviews of trials. Annals of the New York Academy of Sciences 703:314-340.
43. Rambihar, V. S., Baum, M. (2000). A mathematical (chaos and complexity) theory of medicine, health and disease: Refiguring medical thought. In V. S. Rambihar (Ed.), A new chaos based medicine beyond 2000: The response to evidence. Toronto: Vashna Publications.
44. Roy-Byrne, P. P., Sherbourne, C. D., Craske, M. G., Stein, M. B., Katon, W., Sullivan, G., et al. (2003). Moving treatment research from clinical trials to the real world. Psychiatric Services 54(3):327-332.
45. Rutten-Van Molken, M. P. M. H., Van Doorslaer, E. K. V., VanVliet, R. C. J. A. (1994). Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Economics 3:333-345.
46. Saito, Y. A., Locke, G. R., Talley, N. J., Zinsmeister, A. R., Fett, S. L., Melton, L. J., 3rd. (2000). A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. American Journal of Gastroenterology 95(10):2816-2824.
47. Schmid, P., Wischnewsky, M. B., Sezer, O., Bohm, R., Possinger, K. (2002). Prediction of response to hormonal treatment in metastatic breast cancer. Oncology 63(4):309-316.
48. Shaneyfelt, T. M., Mayo-Smith, M. F., Rothwangl, J. (1999). Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. Journal of the American Medical Association 281(20):1900-1905.
49. Simes, R. J. (2002). Clinical trials and "real-world" medicine. Trial evidence best informs real-world medicine when it is relevant to the clinical problem. Medical Journal of Australia 177(8):410-411.
50. Vannemreddy, P., Nanda, A., Kelley, R., Baskaya, M. K. (2001). Delayed diagnosis of intracranial aneurysms: Confounding factors in clinical presentation and the influence of misdiagnosis on outcome. Southern Medical Journal 94(11):1108-1111.
51. Vomweg, T. W., Buscema, M., Kauczor, H. U., Teifke, A., Intraligi, M., Terzi, S., et al. (2003). Improved artificial neural networks in prediction of malignancy of lesions in contrast-enhanced MR-mammography. Medical Physics 30(9):2350-2359.
52. Weinger, M. B., Ancoli-Israel, S. (2002). Sleep deprivation and clinical performance. Journal of the American Medical Association 287:955-957.
53. Zadeh, L. A. (1965). Fuzzy sets. Information and Control 8:338-353.
54. Zadeh, L. A. (1968). Probability measures of fuzzy events. Journal of Mathematical Analysis and Applications 23:421-427.